Beaphar Multiwormer For Cats, Tablets
Revised: 08 June 2010
AN: 00309/2010
SUMMARY OF PRODUCT CHARACTERISTICS
Name of the Veterinary Medicinal Product
Beaphar Multiwormer for Cats, Tablets
Qualitative and Quantitative Composition
Tapeworm tablets (fawn)
Active substance mg/tablet
Dichlorophen 250.00
Excipients mg/tablet
Caramel 15712 (E150) 4.0
For full list of excipients, see section 6.1
Roundworm tablets (pink)
Active substance mg/tablet
Piperazine Citrate 125.00
Excipients mg/tablet
Erythrocine Lake (E127) 0.25
For full list of excipients, see section 6.1
Pharmaceutical form
Tablets
Roundworm tablet: Slightly mottled pink, circular bi-convex tablet embossed with an incomplete break-line on one face.
Tapeworm tablet: Mottled fawn to off-white, circular slightly bi-convex tablet embossed on one face with an incomplete break line.
Clinical Particulars
4.1 Target species
Cats over 6 months of age
Indications for use, specifying the target species
For the treatment of roundworm (Ascarids) and tapeworm infections in cats over six months old
Contra-indications
Do not treat cats less than 6 months old.
Do not repeat the treatment if vomiting occurs shortly after dosing.
4.4 Special warnings for each target species
Do not treat cats under 0.6 kg (1.5 lb), or less than 6 months old.
Do not repeat treatment if the cat vomits after administration.
Special precautions for use
i. Special precautions for use in animals
Consult a veterinary surgeon before treating animals with a history of epilepsy or severe renal dysfunction.
It is important to establish the bodyweight of the animal before treatment to ensure correct dosage administration.
Special precautions to be taken by the person administering the medicinal product to animals
Wash hands thoroughly after handling tablets.
Accidental eye contact – rinse thoroughly with clean running water.
If irritation persists seek medical advice.
Accidental ingestion by humans – drink plenty of water and seek medical advice.
Adverse reactions (frequency and seriousness)
Dichlorophen may cause excessive salivation in some cats, due to its bitter taste. Idiosyncratic reactions to dichlorophen have been recorded in some animals, characterised by ataxia, depression, and occasionally vomiting.
4.7 Use during pregnancy, lactation or lay
Consult a veterinary surgeon before treating pregnant animals.
Nursing female cats should be treated 2 weeks after giving birth and every two weeks until weaning.
4.8 Interaction with other medicinal products and other forms of interaction
None known
4.9 Amounts to be administered and administration route
For oral administration
Treatment consists of three doses given at weekly intervals. Administer one pink tablet per 1.3 kg (3 lb) bodyweight on day 1, then one fawn tablet per 1.3 kg on day 8, and one pink tablet per 1.3 kg on day 15. Tablets may be taken whole, or crushed and sprinkled on the cat’s food. Do not remove tablets from strip until required for treatment.
Cats should be treated every 3 months.
4.10 Overdose (symptoms, emergency procedures, antidotes) if necessary
Piperazine Citrate Dichlorophen
Symptoms: Vomiting and diarrhoea Vomiting
Depression General weakness
Ataxia and muscle weakness Ataxia
Fits
Emergency Procedures: Consult a veterinary surgeon.
Treat symptomatically and supportively.
Keep animal warm and calm.
Symptoms reverse in 24-48 hours.
4.11 Withdrawal period(s)
Not applicable.
Pharmacological properties
ATCvet codes:QP52AG01, QP52AH01
Pharmacodynamic properties
Piperazine acts as an anthelmintic by causing nerve paralysis of the worm, with subsequent expulsion.
Dichlorophen is effective against most common cestodes, and also has antibacterial and antifungal properties.
5.2 Pharmacokinetic particulars
The citrate is quickly absorbed in the cat and excreted in the urine.
Pharmaceutical particulars
List of excipients
Tapeworm tablets (fawn)
Caramel 15712 (E150)
Maize Starch
Pregelatinised Starch
Magnesium Stearate
Roundworm tablets (pink)
Erythrosine Lake (E127)
Cellulose Microcrystalline
Silica Colloidal Anhydrous
Magnesium Stearate
Incompatibilities
None known.
Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
Special precautions for storage
Do not store above 25ºC.
Do not remove tablets from strip until required for treatment
Any part-used tablets should be discarded.
Nature and composition of immediate packaging
8 pink roundworm tablets and 4 fawn tapeworm tablets in the following pack:
Container: PVC – aluminium foil blister strip
Closure: Heat – seal
Secondary pack: One blister of 8 roundworm tablets with one blister of 4 fawn tapeworm tablets per carton.
Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Marketing authorisation holder
Beaphar UK Ltd.
Homefield Road
Haverhill
Suffolk
CB9 8QP
Marketing authorisation number
Vm 13907/4006
Date of first authorisation/renewal of the authorisation
Date of first authorisation: 21 September 1994
Date of revision of the text
June 2010
Page 5 of 5